Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

I am still thinking that Brilacidin might work on the mild to moderate group. The two options being considered now may have the advantage of being orally administered but they have not been proven to work that great and both seem to come with major risks. I think a Brilacidin trial for those in the mild to moderate category might look something like this. The patient presents at the emergency room and a Covid infection is confirmed. A blood sample is taken to establish a baseline and the patient is then given a Brilacidin IV. Follow-up visits and/or blood samples would be utilized at appropriate intervals. Multiple doses would probably be better, but if one dose knocks the Covid back by 90%+, perhaps that is enough for the immune system to get ahead of it. It’s worth a try…